ScinoPharm Taiwan, Ltd. announced the appointment of Jang-Yang Chang and Chyun-Yu Yang as Independent Director, effective May 29, 2023. Resume of the new position holder: Jang-Yang Chang, President of Taipei Cancer Center Distinguished Investigator and Director of Institute of Biotechnology and Pharmaceutical Research, NHRI and Chyun-Yu Yang, Honoring Superintendent and Professor of Department of Orthopedics, Kuo General Hospital Superintendent, National Cheng Kung University Hospital.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.6 TWD | +0.18% | -2.82% | +4.55% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 67Cr | |
+29.98% | 68TCr | |
+30.34% | 57TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- 1789 Stock
- News ScinoPharm Taiwan, Ltd.
- ScinoPharm Taiwan, Ltd. Announces Independent Director Appointments